183 results on '"Hellmuth, Johannes C."'
Search Results
2. Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation
3. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients
4. Molekular zielgerichtete Therapien – brauchen wir überhaupt noch Chemotherapie?
5. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
6. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
7. Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
8. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
9. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients
10. The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up
11. OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity
12. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID‐19 from influenza pneumonia
13. Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage
14. Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
15. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
16. Aktuelle Standards in der Behandlung des Hodgkin Lymphoms
17. Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury
18. CD74 is a functional MIF receptor on activated CD4+ T cells.
19. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles
20. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
21. Myocardial Inflammation and Dysfunction in COVID-19–Associated Myocardial Injury
22. Molekular zielgerichtete Therapien – brauchen wir überhaupt noch Chemotherapie?
23. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
24. Supplementary Table S4 from Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
25. Supplementary Figures S1-S6 from Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
26. Data from Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
27. Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature
28. Thyroidal Angiotensin-Converting Enzyme 2 Protein Expression and Thyroid Function Tests in Patients with COVID-19: Results from a Retrospective Case Series and a Prospective Cohort Study
29. Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections
30. Consistency as a Data Quality Measure for German Corona Consensus items mapped from National Pandemic Cohort Network data collections
31. Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID‐19 and after yellow fever vaccination
32. Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index—Based Prediction of COVID-19-Associated Respiratory Failure
33. 5'-Triphosphate RNA Requires Base-Paired Structures to Activate Antiviral Signaling via RIG-I
34. Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
35. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
36. Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients
37. Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID‐19 and after yellow fever vaccination.
38. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
39. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
40. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020
41. Impaired function and delayed regeneration of dendritic cells in COVID-19
42. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
43. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
44. Differences in Cardiac Magnetic Resonance Imaging Markers Between Patients With COVID-19-associated Myocardial Injury and Patients With Clinically Suspected Myocarditis
45. Anti-SARS-CoV-2 Spike Protein and Anti-Platelet Factor 4 Antibody Responses Induced by COVID-19 Disease and ChAdOx1 nCov-19 vaccination
46. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
47. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
48. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
49. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients
50. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.